Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 12:13:944715.
doi: 10.3389/fendo.2022.944715. eCollection 2022.

The Mysterious Universe of the TSH Receptor

Affiliations
Review

The Mysterious Universe of the TSH Receptor

Inês Henriques Vieira et al. Front Endocrinol (Lausanne). .

Abstract

The thyroid-stimulating hormone receptor (TSH-R) is predominantly expressed in the basolateral membrane of thyrocytes, where it stimulates almost every aspect of their metabolism. Several extrathyroidal locations of the receptor have been found including: the pituitary, the hypothalamus, and other areas of the central nervous system; the periorbital tissue; the skin; the kidney; the adrenal; the liver; the immune system cells; blood cells and vascular tissues; the adipose tissue; the cardiac and skeletal muscles, and the bone. Although the functionality of the receptor has been demonstrated in most of these tissues, its physiological importance is still a matter of debate. A contribution to several pathological processes is evident in some cases, as is the case of Grave's disease in its multiple presentations. Conversely, in the context of other thyroid abnormalities, the contribution of the TSH-R and its ligand is still a matter of debate. This article reviews the several different sites of expression of the TSH-R and its potential role in both physiological and pathological processes.

Keywords: G-protein coupled receptors; TSH receptor autoantibodies; receptors; thyroid; thyroid diseases; thyroid stimulating hormone.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

Cited by

References

    1. Tomer Y, Barbesino G, Keddache M, Greenberg DA, Davies TF. Mapping of a Major Susceptibility Locus for Graves’ Disease (GD-1) to Chromosome 14q31. J Clin Endocrinol Metab (1997) 82(5):1645–8. doi: 10.1210/jcem.82.5.4064 - DOI - PubMed
    1. Rapoport B, McLachlan SM. The Thyrotropin Receptor in Graves’ Disease. Thyroid Off J Am Thyroid Assoc (2007) 17(10):911–22. doi: 10.1089/thy.2007.0170 - DOI - PubMed
    1. Russo D, Chazenbalk GD, Nagayama Y, Wadsworth HL, Seto P, Rapoport B. A New Structural Model for the Thyrotropin (TSH) Receptor, as Determined by Covalent Cross-Linking of TSH to the Recombinant Receptor in Intact Cells: Evidence for a Single Polypeptide Chain. Mol Endocrinol Baltim Md (1991) 5(11):1607–12. doi: 10.1210/mend-5-11-1607 - DOI - PubMed
    1. Chen CR, Chazenbalk GD, Wawrowsky KA, McLachlan SM, Rapoport B. Evidence That Human Thyroid Cells Express Uncleaved, Single-Chain Thyrotropin Receptors on Their Surface. Endocrinology (2006) 147(6):3107–13. doi: 10.1210/en.2005-1514 - DOI - PubMed
    1. Michalek K, Morshed SA, Latif R, Davies TF. TSH Receptor Autoantibodies. Autoimmun Rev (2009) 9(2):113–6. doi: 10.1016/j.autrev.2009.03.012 - DOI - PMC - PubMed

LinkOut - more resources